Matinas BioPharma Holdings Inc (MTNB) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $0.60
• Market Cap: $3.86M
• EPS: $-3.42
• 52-Week High: $3.09
• 52-Week Low: $0.47

About Matinas BioPharma Holdings Inc

Matinas BioPharma Holdings, Inc. (MTNB) is a clinical-stage biopharmaceutical company headquartered in Bedminster, New Jersey, specializing in the development of innovative oral lipid-based delivery systems for therapeutics targeting infectious diseases and chronic conditions. The company aims to enhance treatment efficacy and patient adherence through its proprietary formulations, which are tailored to address significant unmet medical needs. With an expanding pipeline of candidate products ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Matinas BioPharma Holdings Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MTNB pay dividends?

Matinas BioPharma Holdings Inc (MTNB) does not currently pay a regular dividend.

What is MTNB's market cap?

Matinas BioPharma Holdings Inc (MTNB) has a market capitalization of $3.86M with a current stock price of $0.60.